Ocrevus and Hemiparesis - a phase IV clinical study of FDA data
Summary:
Hemiparesis is reported as a side effect among people who take Ocrevus (ocrelizumab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Tylenol, and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people have Hemiparesis when taking Ocrevus. It is created by eHealthMe based on reports of 56,539 people who have side effects when taking Ocrevus from the FDA, and is updated regularly.
What is Ocrevus?
Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.
What is Hemiparesis?
Hemiparesis (weakness on one side of the body) is found to be associated with 1,249 drugs and 1,447 conditions by eHealthMe. Check the latest studies of Hemiparesis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
56,539 people reported to have side effects when taking Ocrevus.
Among them, 401 people (0.71%) have Hemiparesis.

Among these 401 people:
How long have people been on Ocrevus when they have Hemiparesis? *
What is the gender of people who have Hemiparesis when taking Ocrevus? *
What is the age of people who have Hemiparesis when taking Ocrevus? *
What are other drugs people take besides Ocrevus? *
What are other side effects people have besides Hemiparesis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ocrevus and have Hemiparesis?
- Check whether Hemiparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ocrevus:
- Ocrevus (56,583 reports)
Hemiparesis treatments and more:
- Hemiparesis (23,885 reports)
How severe was Hemiparesis and when was it recovered:
Expand to all the drugs that have ingredients of ocrelizumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ocrevus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hemiparesis:
- Hemiparesis (1,249 drugs)
Browse all the conditions that are associated with Hemiparesis:
- Hemiparesis (1,447 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ocrelizumab (the active ingredients of Ocrevus) and Ocrevus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lantus Solostar cause Oral Pain? - a second ago
- Could Jakafi cause Spinal Disorder? - a second ago
- Could Nuvaring cause Peripheral Swelling? - 6 seconds ago
- Could Nuvaring cause Small Intestinal Obstruction? - 7 seconds ago
- Could Asacol cause Abdominal Pain? - 8 seconds ago
- Could Vitamin E cause Haematocrit Decreased? - 13 seconds ago
- Could Synthroid cause Rectal Bleeding? - 13 seconds ago
- Could Fish Oil cause Allergic Sinusitis? - 15 seconds ago
- Could Prograf cause Cholangitis Sclerosing? - 17 seconds ago
- Could Balsalazide Disodium cause Insomnia? - 18 seconds ago